Original ResearchT1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication
Under an Elsevier user license
open archive
Key Words
cardiac magnetic resonance imaging
extracellular matrix
outcome
T1 mapping
Abbreviations and Acronyms
CABG
coronary artery bypass graft
CMR
cardiac magnetic resonance
ECV
extracellular volume
LGE
late gadolinium enhancement
LV
left ventricular
MOLLI
modified Look-Locker inversion
NT-proBNP
N-terminal prohormone brain natriuretic peptide
RV
right ventricular
Cited by (0)
This study received support from the Austrian Society of Cardiology (Dr. Mascherbauer), the Österreichischer Herzfonds (Dr. Mascherbauer) and the Austrian fellowship grant KLI 245 (to Dr. Mascherbauer) and KLI 246 (Dr. Bonderman). Siemens Healthcare GmbH (Erlangen, Germany) provided the T1-mapping prototype as a work-in-progress package but had no influence on study design, data processing, or statistical analysis. Dr. Greiser is an employee of Siemens Healthcare GmbH. Dr. Lang has received grants and speakers’ fees from Actelion Pharmaceuticals, Bayer, United Therapeutics, and AOP Orphan Pharmaceuticals. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.